002437.SZ · 誉衡药业
China A-shares · RS rating 69 · As of 2026-10-14
| Price | 3.30 CNY |
|---|---|
| 1-day change | -3.8% |
| RS rating (overall / 1M / 3M / 12M) | 69 / 13 / 78 / 68 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 38 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -13.2% |
| Distance from 52-week high | +33.7% |
| Market cap (USD) | $1.2B |